RTW Investments’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-53,911
Closed -$8.8M 70
2023
Q3
$8.8M Hold
53,911
0.19% 49
2023
Q2
$17.7M Hold
53,911
0.34% 42
2023
Q1
$14.9M Sell
53,911
-6,732
-11% -$2.47M 0.31% 36
2022
Q4
$23.5M Hold
60,643
0.48% 37
2022
Q3
$14.5M Hold
60,643
0.33% 45
2022
Q2
$13.5M Buy
60,643
+666
+1% +$287K 0.35% 50
2022
Q1
$40.8M Buy
59,977
+334
+0.6% +$201K 0.85% 36
2021
Q4
$41.2M Hold
59,643
0.6% 51
2021
Q3
$44.2M Buy
59,643
+10,500
+21% +$7.15M 0.67% 42
2021
Q2
$36.8M Buy
49,143
+3,333
+7% +$2.55M 0.56% 45
2021
Q1
$37.4M Buy
45,810
+6,805
+17% +$5.25M 0.58% 50
2020
Q4
$33.3M Buy
39,005
+12,005
+44% +$9.25M 0.56% 43
2020
Q3
$20.3M Buy
+27,000
New +$22.2M 0.49% 50

Other funds holding OM

RTW Investments's OM Position: Q4 2023 in Review

RTW Investments sold out of Outset Medical (OM) in Q4 2023, closing a stake of 53,911 shares — an estimated $8.8M sold.

RTW Investments first reported a position in OM in Q3 2020 and held it in 13 quarters. The position peaked at $44.2M in Q3 2021. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • RTW Investments reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • RTW Investments sold 53,911 Outset Medical shares in Q4 2023, an estimated $8.8M.
  • RTW Investments first reported a position in Outset Medical in Q3 2020 and held it in 13 quarters.
  • RTW Investments's Outset Medical position peaked at $44.2M in Q3 2021.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on RTW Investments's 13F filing for Q4 2023, filed 14 Feb 2024.